| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
| 06/05/2001 | US6242230 Process for microencapsulating cells |
| 06/05/2001 | US6242099 Encapsulation |
| 06/05/2001 | US6242008 Spherical pharmaceutical granules comprising microcrystalline cellulose and a process for their production |
| 06/05/2001 | US6242007 Reacting pyrithione or water soluble salt with polyvalent metal salt; stabilization |
| 06/05/2001 | US6242006 β-lactam granules free of organic solvents |
| 06/05/2001 | US6242005 Crushed grape extract solvent extracted with acetone and ethyl acetate |
| 06/05/2001 | US6242004 Bioadhesive tablets |
| 06/05/2001 | US6242003 Organic compounds |
| 06/05/2001 | US6242002 Rapidly disintegrating oral dosage form of alkali-sensitive material, effervescent base of alkaline earth metal carbonate, organic edible acid and alkali metal salt of citric acid, auxiliary ingredients |
| 06/05/2001 | US6242001 Method for producing dispersible sterol and stanol compounds |
| 06/05/2001 | US6242000 Analgesic, antiinflammatory agent |
| 06/05/2001 | US6241999 Substituting first amphipathic lipid with one having a similiar structure but more c atoms |
| 06/05/2001 | US6241998 Containing polymeric adhesive composition adhered to lower surface of pad for physical removal of keratotic plugs from the skin |
| 06/05/2001 | US6241997 Chewable calcium supplement and method |
| 06/05/2001 | US6241993 Therapeutic/cosmetic compositions comprising bradykinin antagonists for treating sensitive human skin |
| 06/05/2001 | US6241983 Bacteria-and fiber-containing composition for human gastrointestinal health |
| 06/05/2001 | US6241975 Method for preparation of plant extract powder |
| 06/05/2001 | US6241969 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 06/05/2001 | US6241967 Process and device for the production of liquid, disperse systems |
| 06/05/2001 | US6241812 Acid-stable and cationic-compatible cellulose compositions and methods of preparation |
| 06/05/2001 | US6241529 Affixing dosage unit comprised of a compressed tablet of a bioerodible polymeric carrier and androgenic agent, progestin, and estrogen to buccal mucosa; useful for female hormone replacement therapy, contraception, and sexual dysfunction |
| 06/05/2001 | CA2209073C Pharmacologic management of snoring |
| 06/05/2001 | CA2198852C Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/05/2001 | CA2146298C Cosmetic and/or dermatological composition with a hydrophilic support and vitamin c extemporaneously mixable |
| 06/05/2001 | CA2051621C Oil-in-water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug |
| 06/05/2001 | CA2039053C Material for adsorbing pyrogen |
| 06/04/2001 | CA2327536A1 Particulate composite material for the controlled release of an active ingredient |
| 05/31/2001 | WO2001038552A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038002A1 Aerosol airflow control system and method |
| 05/31/2001 | WO2001037896A2 Methods and compositions for administration of therapeutic reagents |
| 05/31/2001 | WO2001037890A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 05/31/2001 | WO2001037883A1 Complexes of alkylphosphonic acids |
| 05/31/2001 | WO2001037880A1 Tablets comprising micro-organisms and method for preparation of the tablets |
| 05/31/2001 | WO2001037879A1 Polyion complex micelles of core/shell structure |
| 05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | WO2001037851A2 Use of ubiquinone q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies |
| 05/31/2001 | WO2001037848A1 Mixture of pomegranate seed oil and juice products |
| 05/31/2001 | WO2001037847A2 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | WO2001037843A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | WO2001037842A1 Remedies for periodontosis |
| 05/31/2001 | WO2001037841A1 Pharmaceutical compositions comprising trimegestone |
| 05/31/2001 | WO2001037840A1 Methods for treating mild cognitive impairment |
| 05/31/2001 | WO2001037839A1 Pernasal preparation |
| 05/31/2001 | WO2001037838A1 Ophthalmic aqueous preparation |
| 05/31/2001 | WO2001037834A1 Stable acid labile benzimidazole pharmaceutical compositions |
| 05/31/2001 | WO2001037828A1 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO2001037817A1 Method for producing a moulded body containing starch |
| 05/31/2001 | WO2001037816A2 Coating of tablet cores |
| 05/31/2001 | WO2001037815A1 Osmotic dosage form comprising first and second |
| 05/31/2001 | WO2001037814A1 Bilayered buccal tablets comprising nicotine |
| 05/31/2001 | WO2001037813A2 Multilayer preparation for a controlled, pulsed release of active substances |
| 05/31/2001 | WO2001037812A2 Gastroretentive controlled release pharmaceutical dosage forms |
| 05/31/2001 | WO2001037811A1 Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| 05/31/2001 | WO2001037810A2 In ovo delivery of an immunogen containing implant |
| 05/31/2001 | WO2001037809A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037807A1 Modular targeted liposomal delivery system |
| 05/31/2001 | WO2001037806A1 Composition and method for treatment of otitis media |
| 05/31/2001 | WO2001037805A1 Pharmaceutical formulations of salmeterol |
| 05/31/2001 | WO2001037804A2 Preservation and formulation of bioactive materials |
| 05/31/2001 | WO2001037803A2 Responsive polymeric hollow particles |
| 05/31/2001 | WO2001037802A1 Sustained percutaneous delivery of a biologically active substance |
| 05/31/2001 | WO2001037783A2 Article comprising a diffuser with flow control features |
| 05/31/2001 | WO2001037782A2 Method and composition for the treatment of scars |
| 05/31/2001 | WO2001037770A1 Improved transdermal contraceptive delivery system and process |
| 05/31/2001 | WO2001005411A8 Compositions addressing inflammation and/or degenerative disorders |
| 05/31/2001 | WO2000077188A3 Dna pcv vaccine |
| 05/31/2001 | WO2000072806A3 Sunscreen composition containing sol-gel microcapsules |
| 05/31/2001 | WO2000069414A3 Granules containing a plant substance and method for producing the same |
| 05/31/2001 | WO2000067723A3 Form of administration for applying in body orifices |
| 05/31/2001 | WO2000064414A3 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 05/31/2001 | WO2000064404A3 Mousse forming hair treatment composition |
| 05/31/2001 | US20010002411 Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
| 05/31/2001 | US20010002406 Administering an anesthetic to the area where capsaicin or an analogue are administered transdermally for neuropathic pain; kits containing two patches; desensitization of C fibers; peripheral neuropathy |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | US20010002290 Comprising allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectant |
| 05/31/2001 | US20010002283 Apparatus for clamping a planar substrate |
| 05/31/2001 | US20010002263 Complex of human growth hormone and zinc and use |
| 05/31/2001 | US20010002262 An active formulation chamber containing active agent and having a fluid passing the active agent retainer is placed at a first end into a fluid and second end into patient mouth to deliver the active agent when patient sips on second end |
| 05/31/2001 | US20010002261 Microencapsulated bioactive agents and method of making |
| 05/31/2001 | US20010002260 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same |
| 05/31/2001 | US20010002259 Applying a transdermal delivery system containing analgesicbuprenorphine sufficient to maintain an adequate onto the skin of the patient and maintaining the relative release rate to provide a specific plasma concentration |
| 05/31/2001 | US20010002257 Amino acid or oligopeptide together with tannin rich plant extract selected from rathania, tea, cinnamon, willow or witch hazel; useful for treating acne, antiaging agent of skin or treating scalp |
| 05/31/2001 | US20010002251 Intracellular sensitizers for sonodynamic therapy |
| 05/31/2001 | DE19957710A1 Treating female type androgenetic or diffuse alopecia by topical administration of melatonin, causing e.g. reduction of telogen rate and increase of anagen rate, hair diameter and tensile strength |
| 05/31/2001 | DE19956848A1 Curcumin-Formulierungen Curcumin formulations |
| 05/31/2001 | DE19954421A1 Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen Preparation in film form for biphasic release of pharmacologically active substances or other |
| 05/31/2001 | DE19954420A1 Zubereitung, bestehend aus einer film-, folien- oder oblatenförmigen Darreichungsform mit zweischichtigem Aufbau und integrierter Kennzeichnung Preparation consisting of a film, foil or wafer-like dosage form two-layer construction and integrated labeling |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2396431A1 Sustained percutaneous delivery of a biologically active substance |
| 05/31/2001 | CA2392356A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | CA2392353A1 Stable acid labile benzimidazole pharmaceutical compositions |
| 05/31/2001 | CA2391986A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 05/31/2001 | CA2391964A1 Polyion complex micelles of core-shell structure |
| 05/31/2001 | CA2391962A1 Multilayer preparation for a controlled, pulsed release of active substances |
| 05/31/2001 | CA2391922A1 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | CA2391606A1 Modular targeted liposomal delivery system |